
### [NCIT:C7175](http://purl.obolibrary.org/obo/NCIT_C7175)
**Label:** Acute Myeloid Leukemia with Recurrent Genetic Abnormalities

**Subclasses:** [NCIT:C7968](http://purl.obolibrary.org/obo/NCIT_C7968) (Childhood Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C3182](http://purl.obolibrary.org/obo/NCIT_C3182) (Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C82423](http://purl.obolibrary.org/obo/NCIT_C82423) (Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214), [NCIT:C9288](http://purl.obolibrary.org/obo/NCIT_C9288) (Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1), [NCIT:C82403](http://purl.obolibrary.org/obo/NCIT_C82403) (Acute Myeloid Leukemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A), [NCIT:C82426](http://purl.obolibrary.org/obo/NCIT_C82426) (Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C82427](http://purl.obolibrary.org/obo/NCIT_C82427) (Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.3); RBM15-MKL1), [NCIT:C27757](http://purl.obolibrary.org/obo/NCIT_C27757) (Microgranular Acute Promyelocytic Leukemia), [NCIT:C27756](http://purl.obolibrary.org/obo/NCIT_C27756) (Typical Acute Promyelocytic Leukemia), [NCIT:C9287](http://purl.obolibrary.org/obo/NCIT_C9287) (Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C122688](http://purl.obolibrary.org/obo/NCIT_C122688) (Core Binding Factor Acute Myeloid Leukemia), [NCIT:C68698](http://purl.obolibrary.org/obo/NCIT_C68698) (Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C68699](http://purl.obolibrary.org/obo/NCIT_C68699) (Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1), [NCIT:C68696](http://purl.obolibrary.org/obo/NCIT_C68696) (Adult Acute Myeloid Leukemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A), [NCIT:C68697](http://purl.obolibrary.org/obo/NCIT_C68697) (Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11), [NCIT:C6924](http://purl.obolibrary.org/obo/NCIT_C6924) (Acute Myeloid Leukemia with Variant MLL Translocations), [NCIT:C9019](http://purl.obolibrary.org/obo/NCIT_C9019) (Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C122716](http://purl.obolibrary.org/obo/NCIT_C122716) (Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C9018](http://purl.obolibrary.org/obo/NCIT_C9018) (Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11), [NCIT:C122717](http://purl.obolibrary.org/obo/NCIT_C122717) (Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C9155](http://purl.obolibrary.org/obo/NCIT_C9155) (Adult Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C38377](http://purl.obolibrary.org/obo/NCIT_C38377) (Acute Myeloid Leukemia with t(17;17)(q21;q21)), [NCIT:C68700](http://purl.obolibrary.org/obo/NCIT_C68700) (Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities), [NCIT:C36058](http://purl.obolibrary.org/obo/NCIT_C36058) (Acute Myeloid Leukemia with t(11;17)(q13;q21)), [NCIT:C36057](http://purl.obolibrary.org/obo/NCIT_C36057) (Acute Myeloid Leukemia with t(5;17)(q35;q21)), [NCIT:C36056](http://purl.obolibrary.org/obo/NCIT_C36056) (Acute Myeloid Leukemia with t(11;17)(q23;q21)), [NCIT:C36055](http://purl.obolibrary.org/obo/NCIT_C36055) (Acute Myeloid Leukemia with a Variant RARA Translocation), [NCIT:C129786](http://purl.obolibrary.org/obo/NCIT_C129786) (Acute Myeloid Leukemia with Mutated RUNX1), [NCIT:C129785](http://purl.obolibrary.org/obo/NCIT_C129785) (Acute Myeloid Leukemia with BCR-ABL1), 

**Class expressions from DL-Learner:**

- [NCIT:C80329](http://purl.obolibrary.org/obo/NCIT_C80329) (Recurrent Genetic Abnormalities Present) 62.50%
- [NCIT:C35788](http://purl.obolibrary.org/obo/NCIT_C35788) (Hypercellular Bone Marrow) 62.50%
- Thing 51.30%
- [NCIT:C36292](http://purl.obolibrary.org/obo/NCIT_C36292) (Laboratory Test Result) 30.49%
- [NCIT:C77140](http://purl.obolibrary.org/obo/NCIT_C77140) (Clinical Test Result) 30.38%
- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 28.13%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 27.52%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 26.92%
- [NCIT:C36346](http://purl.obolibrary.org/obo/NCIT_C36346) (Fusion Protein Expression) 19.72%
- [NCIT:C36345](http://purl.obolibrary.org/obo/NCIT_C36345) (Protein Deregulation) 19.12%
- [NCIT:C36336](http://purl.obolibrary.org/obo/NCIT_C36336) (Deregulation of Protein and Messenger RNA Expression) 18.52%
- [NCIT:C36541](http://purl.obolibrary.org/obo/NCIT_C36541) (Chromosomal Rearrangement) 16.65%
- [NCIT:C36327](http://purl.obolibrary.org/obo/NCIT_C36327) (Gene Abnormality) 16.62%
- [NCIT:C36278](http://purl.obolibrary.org/obo/NCIT_C36278) (Finding by Site or System) 16.53%
- [NCIT:C36391](http://purl.obolibrary.org/obo/NCIT_C36391) (Molecular Genetic Variation) 16.14%


